3 AI-Driven Medical Device Stocks to Watch in 2025
NVIDIA NVDA cofounded the Medical Open Network for AI ('MONAI') with the world's leading academic medical centers to establish an inclusive community of AI researchers, developing and exchanging best practices for AI in healthcare imaging across academia and enterprise researchers. Additionally, Gen AI powers real-time clinical documentation tools embedded within diagnostic devices, such as Nuance Communications's Dragon Ambient eXperience ('DAX'). These devices transcribe doctor-patient conversations into structured clinical notes, minimizing administrative burden and enhancing documentation accuracy.
Alternatively, agentic AI enables medical devices to act autonomously and make decisions based on real-time data. Agentic AI also supports predictive maintenance in connected medical equipment, such as MRIs and ventilators. This enables fault detection and automated service scheduling, thereby reducing equipment downtime. In the surgical field, AI-guided robotic systems, such as Intuitive Surgical's ISRG da Vinci platform, are integrating agentic AI features to assist with real-time tissue navigation and instrument movement.
Here, we have picked three medical devices stocks, namely Boston Scientific Corporation BSX, Johnson & Johnson JNJ and GE HealthCare Technologies Inc. GEHC, which are likely to perform well in 2025, driven by strong AI adoption.
Rising Demand for Precision and Personalized Medicine: AI enables medical devices to deliver highly individualized diagnostics and treatments. For instance, AI algorithms can analyze patient-specific imaging data or genetic profiles to guide the design of implants, surgical plans, or therapeutic regimens, improving patient outcomes.
Favorable Regulatory Environment: Regulatory oversight for AI in the United States falls under the FDA's Software as a Medical Device (SaMD) segment. Over 700 AI-enabled devices have been approved, which is more than 10 times the number available in 2020. In January, the FDA released a draft guidance on adaptive AI systems, which have reduced uncertainty for developers, encouraging innovation and faster approvals.
Boston Scientific is a major manufacturer of interventional medical devices. The company has been investing in AI to support its devices and improve procedural outcomes. It's HeartLogic is a heart failure diagnostic that utilizes AI to detect worsening heart failure in patients with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds). The Rhythm AI module in the Rhythmia HDx mapping system can automatically interpret electroanatomical maps to identify arrhythmia circuits, enabling electrophysiologists to target ablation therapy more effectively. Meanwhile, the company's Coronary Advanced Analysis software uses AI to analyze optical coherence tomography images to characterize plaque.
Boston Scientific, carrying a Zacks Rank #2 (Buy) at present, has a projected 2025 sales growth rate of 16.4%, higher than the industry's flat growth. The company has a favorable current cashflow rate of 26.5% against the industry's -2.6%. For 2025, its earnings are expected to grow 15.9%.
Boston Scientific Corporation price | Boston Scientific Corporation Quote
Johnson & Johnson is a healthcare conglomerate with a major MedTech division (Johnson & Johnson MedTech) focused on medical devices and diagnostics. The company employs AI for surgical robotics, digital surgery analytics and imaging. It has developed an ecosystem called Ottava, its next-gen robotic surgery platform, and the Caresurgical/VELYS digital surgery systems, which use data and AI for procedure planning. Its Polyphonic Digital Ecosystem connects operating rooms, allowing surgeons to share live video and data with remote peers. AI in this system helps identify significant events in the surgery video feed for discussion.
Johnson & Johnson, carrying a Zacks Rank #2 at present, has a historical earnings growth rate of 5.5%, higher than the industry's 2.8%. The company has a net margin of 24.4%, outperforming the industry's 18.6%. For 2025, its sales are expected to grow 2.8%.
Johnson & Johnson price | Johnson & Johnson Quote
GE HealthCare is a global leader in medical imaging, diagnostics and healthcare. AI is central to the company's digital strategy, which focuses on its precision care framework. In 2023, it topped the FDA list of AI-enabled medical devices with 80 listed 510(k) clearances or authorizations to date in the United States. Recently, the company has launched CleaRecon DL — an AI-driven solution that enhances cone-beam computed tomography image quality. Also, its Invenia Automated Breast Ultrasound Premium, the latest 3D ultrasound, offers advanced AI and innovative features to drive faster, reproducible supplemental screening and streamline exam readings on patients with dense breasts.
GE HealthCare, carrying a Zacks Rank #3 (Hold) at present, has a projected 2025 sales growth rate of 3.2%, higher than the industry's flat growth. The company has a favorable current cashflow rate of 9.7% against the industry's -2.6%.
GE HealthCare Technologies Inc. price | GE HealthCare Technologies Inc. Quote
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Boston Scientific Corporation (BSX) : Free Stock Analysis Report
Johnson & Johnson (JNJ) : Free Stock Analysis Report
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
GE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Professional Triathlon Organisation announces Series C funding boost
The Professional Triathletes Organisation has announced a new injection of funding to help in their mission to redefine endurance sport. The successful completion of a Series C funding round, led by SURJ Sports Investment and supported by Cordillera, Verance Capital and Sir Michael Moritz, will support the PTO's continued growth in international markets as well as building long-term athlete and fan engagement. PTO CEO Sam Renouf welcomed the news, with the hopes that further funding can also help propel their T100 Triathlon World Tour to greater heights. 'We're delighted to welcome SURJ and Verance Capital to the PTO investor family," he said. "This is a major milestone not only for us as an organisation, but for the broader vision of triathlon's future. "Our goal has always been to reimagine the sport for modern audiences and open up participation to athletes of all levels. "With new partners like SURJ and Verance, we're better equipped than ever to scale our ambitions globally. "The momentum from our record-breaking T100 Singapore event is just the beginning of what we hope to achieve in 2025 and beyond.' The Series C investment comes at a time of growth for the PTO. In 2024, the organisation launched the T100 Tour and the event has rapidly expanded in the past 18 months. With the wellbeing of professional athletes at its heart and widespread fan participation events, the T100 has attracted thousands of eyes to the endurance sport in less than two years and a new round of funding will be viewed as a critical opportunity to only further enhance it's position amongst elite sport.
Yahoo
19 minutes ago
- Yahoo
Does Tesla Become More Valuable for Investors When Elon Musk Gets Richer?
Tesla CEO Elon Musk, among many other things, is famous for being the wealthiest human being on Earth. Currently, Musk's estimated net worth runs between a staggering $400 billion and $425 billion –that's almost twice the wealth of the next-richest person in the world, Mark Zuckerberg. A great deal of Musk's wealth stems from Tesla, the automotive company he invested in in 2004 and later became CEO of. Musk owned 20% of Tesla stock in late 2020, when the car company's valuation skyrocketed, thus creating 75% of Musk's now incredible wealth, per The Guardian. As such, Musk's wealth is irrevocably intertwined with Tesla's value. Find Out: Read Next: That doesn't mean that Tesla becomes more valuable for its investors when Elon Musk gets richer, though; rather, the inverse is true. According to The Verge, Musk has a compensation plan with Tesla that forgoes an annual salary; instead, Musk's compensation is generated by Tesla's profits and stock values — the billionaire only receives payment if Tesla hits specific stock market heights. This means that the more Tesla's stock rises, the richer Elon Musk becomes. Tesla does not become more valuable for investors when Musk gets richer, instead, Musk gets richer when Tesla becomes more valuable for investors. In that way, Musk is somewhat like the average Tesla stockholder himself — he profits when the company does well (he is, however, unlike most investors in that he makes millions upon millions in this scenario). Even though Musk's wealth can't increase the value of Tesla for stockholders, the world's richest man does have the power to influence the company's value. Musk, in addition to being the richest person on Earth, is also one of the most famous, with his every move under seemingly endless scrutiny. He has the ability to change and impact Tesla's valuation, profits and momentum via his public behavior. For instance, his controversial involvement with the second Trump administration (including DOGE) drew harsh criticism, which led to steep declines in Tesla stock and value. Additionally, his subsequent exit from the Trump administration led to an uptick in Tesla stock, which increased Musk's considerable wealth. Bottom line: When Musk gets richer, that is usually a good thing for Tesla investors, as it's a sign they'll be getting richer, too. It's just that his wealth isn't the source of their success, it's merely a large result of it. More From GOBankingRates 5 Cities You Need To Consider If You're Retiring in 2025 This article originally appeared on Does Tesla Become More Valuable for Investors When Elon Musk Gets Richer? Sign in to access your portfolio
Yahoo
19 minutes ago
- Yahoo
Similarweb Launches GenAI Intelligence Toolkit, Tracking Visibility and Traffic Across AI Chatbots
New offering delivers a full-funnel view of brand performance – measuring where your brand is seen and how much traffic it receives, versus competitors, from platforms like ChatGPT. TEL AVIV, Israel, July 28, 2025--(BUSINESS WIRE)--Similarweb's new GenAI Intelligence Toolkit is an innovative solution combining AI Brand Visibility and AI Traffic, letting companies see how they are represented on AI platforms and the value of AI-generated traffic to their digital marketing and sales. As generative AI begins to shift the overall digital marketing mix away from traditional search, marketers, merchants, and digital leaders are seeking to understand when AI chatbots are recommending their business and how much traffic they drive to company websites. In June 2025, AI platforms including ChatGPT, Gemini, Perplexity, Grok, and CoPilot generated more than 1.1 billion referral visits, a year-over-year increase of 357%, according to Similarweb estimates. Similarweb's GenAI Intelligence Toolkit distinguishes itself by providing both visibility and traffic data for GenAI, giving businesses a comprehensive picture of their performance across AI-powered discovery and search tools. The GenAI Intelligence Toolkit gives brands the ability to: Connect visibility and traffic. Lets brands understand their performance across AI platforms. See where your brand is (and isn't) showing up. AI Brand Visibility shows brands which topics are most associated with the company and the top cited sources within AI answers. For example, you can identify when an AI platform is being influenced by news outlets or review sites that favor your competitors, enabling you to strategically prioritize improving your visibility and placement within those channels. Benchmark and act. GenAI Intelligence Toolkit users gain visibility into the volume of AI-driven traffic to their landing pages and those of their competitors and what prompts are generating traffic. Understand AI traffic. Traffic still matters. Conversions, engagement, and revenue happen after the click. Gen AI Intelligence arms you with the knowledge you need to optimize your content and strategy to boost traffic for the AI channel. Gain new consumer insight. Unlike traditional search keywords, detailed AI queries offer deeper insight into consumer intent, enabling more precise analysis and targeted engagement. While other AI brand visibility tools exist, visibility alone is not enough. Similarweb's GenAI Intelligence Toolkit goes further, identifying which ones drive traffic to specific pages. Powered by Similarweb's industry-leading Digital Data, it uniquely enables organizations to measure traffic to their own properties and also benchmark against competitor performance, offering a comprehensive view of how generative AI is reshaping the landscape. See our blog post for more details. What Similarweb Customers Are Saying "With AI searches on the rise and featured heavily within industry news, I get asked a lot of questions on the regular by senior company executives – they want to know how much of our traffic is coming from AI platforms, and what this might mean for our future strategy," says Jon Baldwin, Senior SEO Content Manager at pet care company Rover. "Similarweb's tool has enabled me to quickly and easily answer these questions with compelling visuals, which senior leaders always appreciate – especially if they're presenting to their board or other business partners." "Similarweb's AI Traffic feature is a game changer, offering valuable insights into how AI chatbots are reshaping brand discovery," agrees Ben Newman, Insights and Effectiveness Manager at Anything is Possible, a UK digital agency. "The AI Traffic feature supports our SEO and Content teams, while also revealing the prompts users are entering, helping us better understand client audiences and what matters to them before they visit a website." "Our SEO team is able to benchmark against competition and understand better our share in AI platforms," says Piotr Szpakiewicz, SEO Growth Leader at "A second feature I like is AI Brand Visibility, which allows me to evaluate our current brand visibility and mention share, but, more importantly, gives us a glimpse into real user prompts. With this AI tracking setup, we can understand how our SEO tech and content translate strategies into chatbot traffic, which prompts triggered mentions of our brand, and where we are cited as a source." Part of Similarweb's Broader AI Initiatives "We recognize that AI represents a fundamental shift in the digital marketplace," says Or Offer, founder and CEO of Similarweb. "We are committed to helping our customers understand how business and consumer use of AI is reshaping the web. At the same time, we're taking advantage of AI across our product development and engineering organizations to improve data analysis and make insights more accessible to our customers. With our recent launch of full-service AI Agents, we're also putting that power in the hands of our customers – for example, agents to help marketers identify search traffic trends and fill content gaps." The Gen AI Intelligence Toolkit is available now. Similarweb Gen AI Data in the News Journalists seeking to help their readers understand the impact of Gen AI are invited to send their questions to press@ Recent coverage includes: The Washington Post, Digiday, MediaPost, TechCrunch, Press Gazette, and others reported on the increase in referral traffic AI platforms are driving to news and media websites – even as publishers worry that AI summaries of their content are depriving them of readers. TechCrunch based its report on the websites receiving the most AI referral traffic by industry category on Similarweb data. As part of our work with journalists covering Amazon's Prime Day promotion in June, Similarweb data revealed that ChatGPT prompts including the words "Prime Day" increased 101% compared to 2024 – suggesting that more consumers were looking to chatbots for advice on the best deals. About Similarweb Similarweb powers businesses to win their markets with Digital Data. By providing essential web and app data, analytics, and insights, we empower our users to discover business opportunities, identify competitive threats, optimize strategy, acquire the right customers, and increase monetization. Similarweb products are integrated into users' workflow, powered by advanced technology, and based on leading comprehensive Digital Data. Learn more: Similarweb | Similarweb Digital Data Free Tools: Analyze any website or app | Verify your website | Browser extension Follow us: Blog | LinkedIn | YouTube | Instagram | X Disclaimer: All names, brands, trademarks, and registered trademarks are the property of their respective owners. The data, reports, and other materials provided or made available by Similarweb consist of or include estimated metrics and digital insights generated by Similarweb using its proprietary algorithms, based on information collected by Similarweb from multiple sources using its advanced data methodologies. Similarweb shall not be responsible for the accuracy of such data, reports, and materials, and shall have no liability for any decision made or action taken by any third party based in whole or in part on such data, reports, and materials. View source version on Contacts Press: David F. Investors: Rami Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
